Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| 1 |
Apple
AAPL
|
+$3.05B |
| 2 |
Broadcom
AVGO
|
+$1.54B |
| 3 |
NVIDIA
NVDA
|
+$1.43B |
| 4 |
Microsoft
MSFT
|
+$1.3B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.66B |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.21B |
| 3 |
Imperial Oil
IMO
|
+$797M |
| 4 |
Vale
VALE
|
+$561M |
| 5 |
Canadian Natural Resources
CNQ
|
+$543M |
Sector Composition
| 1 | Technology | 23.76% |
| 2 | Financials | 9.79% |
| 3 | Healthcare | 8.86% |
| 4 | Consumer Discretionary | 8.78% |
| 5 | Industrials | 6.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Schwab US Broad Market ETF
SCHB
$36.8B
| $26.3M | ﹤0.01% |
1,255,743
+808,425
| +181% | +$16.9M |
|
|
NXRT
1402
NexPoint Residential Trust
NXRT
$858M
| $26.3M | ﹤0.01% |
665,990
+50,206
| +8% | +$1.98M |
|
1403
Vital Energy
VTLE
$635M
| $26.3M | ﹤0.01% |
586,849
+206,241
| +54% | +$9.24M |
|
1404
Day One Biopharmaceuticals
DAWN
$729M
| $26.2M | ﹤0.01% |
1,903,108
-234,383
| -11% | -$3.23M |
|
1405
Churchill Downs
CHDN
$6.75B
| $26.2M | ﹤0.01% |
187,853
+41,260
| +28% | +$5.76M |
|
1406
Idacorp
IDA
$6.77B
| $26.2M | ﹤0.01% |
281,056
+25,932
| +10% | +$2.42M |
|
1407
CACI
CACI
$10.9B
| $26.1M | ﹤0.01% |
60,740
+6,076
| +11% | +$2.61M |
|
1408
Warrior Met Coal
HCC
$3.04B
| $26.1M | ﹤0.01% |
416,105
+42,956
| +12% | +$2.7M |
|
1409
Exelixis
EXEL
$10.5B
| $26M | ﹤0.01% |
1,156,809
+250,525
| +28% | +$5.63M |
|
1410
Olin
OLN
$3.02B
| $26M | ﹤0.01% |
550,947
+137,796
| +33% | +$6.5M |
|
1411
Perella Weinberg Partners
PWP
$1.43B
| $26M | ﹤0.01% |
1,598,475
-252,251
| -14% | -$4.1M |
|
1412
Mirum Pharmaceuticals
MIRM
$3.73B
| $26M | ﹤0.01% |
759,018
+58,902
| +8% | +$2.01M |
|
1413
LXP Industrial Trust
LXP
$2.72B
| $25.9M | ﹤0.01% |
2,840,890
+408,500
| +17% | +$3.73M |
|
1414
Glaukos
GKOS
$4.75B
| $25.9M | ﹤0.01% |
218,717
-11,703
| -5% | -$1.39M |
|
1415
Kemper
KMPR
$3.35B
| $25.9M | ﹤0.01% |
436,273
+57,939
| +15% | +$3.44M |
|
1416
Ultragenyx Pharmaceutical
RARE
$2.92B
| $25.9M | ﹤0.01% |
629,514
+265,392
| +73% | +$10.9M |
|
1417
First Bancorp
FBP
$3.49B
| $25.9M | ﹤0.01% |
1,414,403
+27,479
| +2% | +$503K |
|
1418
Enpro
NPO
$4.64B
| $25.8M | ﹤0.01% |
177,545
+33,264
| +23% | +$4.84M |
|
1419
First Merchants
FRME
$2.31B
| $25.8M | ﹤0.01% |
774,527
-5,922
| -0.8% | -$197K |
|
1420
United Therapeutics
UTHR
$18.3B
| $25.7M | ﹤0.01% |
80,710
+22,234
| +38% | +$7.08M |
|
1421
Dycom Industries
DY
$7.47B
| $25.7M | ﹤0.01% |
152,334
+40,755
| +37% | +$6.88M |
|
1422
W.P. Carey
WPC
$15B
| $25.7M | ﹤0.01% |
466,276
+224,950
| +93% | +$12.4M |
|
1423
FirstCash
FCFS
$6.49B
| $25.6M | ﹤0.01% |
244,484
+25,174
| +11% | +$2.64M |
|
1424
Albertsons Companies
ACI
$10.5B
| $25.6M | ﹤0.01% |
1,295,799
-8,502,312
| -87% | -$168M |
|
1425
Alamos Gold
AGI
$13.9B
| $25.5M | ﹤0.01% |
1,623,312
+611,715
| +60% | +$9.59M |
|